logo
ProjectActive

Siegfried

Active · Mexico

Source: IFC Project Disclosures

   Founded 45 years ago, Siegfried Rhein, S.A. de C.V. (“Siegfried” or the “company”) is a Mexico-based, pharmaceutical company focused on the development, manufacture and sales of generic medicines.  Siegfried is one of the leading domestic pharmaceutical company in Mexico, primarily focused on prescription generics, with a portfolio of 89 products covering the following thera

Status
Prospective
Sector
Manufacturing (Industrial)
Location
Mexico
Updated
19 Nov 2026
Source
IFC Project Disclosures

ConstructChat

Ask ConstructChat about Siegfried

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Siegfried” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Mexico. Taiyo aggregates data on it from IFC Project Disclosures.

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

   Founded 45 years ago, Siegfried Rhein, S.A. de C.V. (“Siegfried” or the “company”) is a Mexico-based, pharmaceutical company focused on the development, manufacture and sales of generic medicines.  Siegfried is one of the leading domestic pharmaceutical company in Mexico, primarily focused on prescription generics, with a portfolio of 89 products covering the following therapeutic areas: analgesics, antibiotics, cardiovascular, gastrointestinal, women’s health, central nervous system, and pediatrics.  The company has one of the largest pharmaceutical sales forces in Mexico and employs more than 1,200 people. Siegfried owns two manufacturing facilities totaling 10,000 m2 in the Benito Juarez industrial park in the city of Queretaro, Mexico (https://goo.gl/maps/Tw7qdAiiNas).  Siegfried is a fully-owned subsidiary of Laboratórios Roemmers S.A. Privately-owned Roemmers is the largest company in the Argentinian pharmaceutical market, and the 5th largest in Latin America. Roemmers is also an existing IFC client (viz. Farmoquimica Brazil, IFC project #39739 - https://disclosures.ifc.org/#/projectDetail/ESRS/39739).   The IFC’s proposed financing aims to support Siegfried’s expansion plan which includes the acquisition of additional brands, regional expansion in Central America, and other expenditures associated with Siegfried’s expansion plan (the “project”).  The total Project Cost is estimated at approximately US$200 million.  The proposed IFC investment is an up to US$60 million corporate A Loan for IFC’s own account plus mobilization of up to US$120 million.                                                

Original sector

other

Location

Country

Mexico

Source

Source

IFC Project Disclosures

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2026-09-09

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project